Macquarie Group’s Inovio Pharmaceuticals INO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | – | Sell |
-125
| Closed | -$1.01K | – | 1787 |
|
|
2024
Q2 | $1.01K | Sell |
125
-714
| -85% | -$5.77K | ﹤0.01% | 1839 |
|
|
2024
Q1 | $12 | Buy |
+839
| New | +$12 | ﹤0.01% | 1717 |
|
|
2022
Q4 | – | Sell |
-441
| Closed | -$14K | – | 2052 |
|
|
2022
Q3 | $14K | Sell |
441
-257
| -37% | -$8.16K | ﹤0.01% | 2288 |
|
|
2022
Q2 | $14K | Hold |
698
| – | – | ﹤0.01% | 2391 |
|
|
2022
Q1 | $30 | Hold |
698
| – | – | ﹤0.01% | 2292 |
|
|
2021
Q4 | $42K | Hold |
698
| – | – | ﹤0.01% | 2210 |
|
|
2021
Q3 | $60K | Hold |
698
| – | – | ﹤0.01% | 2167 |
|
|
2021
Q2 | $78K | Hold |
698
| – | – | ﹤0.01% | 2040 |
|
|
2021
Q1 | $78K | Buy |
698
+192
| +38% | +$21.5K | ﹤0.01% | 1968 |
|
|
2020
Q4 | $54K | Hold |
506
| – | – | ﹤0.01% | 2020 |
|
|
2020
Q3 | $70K | Hold |
506
| – | – | ﹤0.01% | 1869 |
|
|
2020
Q2 | $164K | Buy |
+506
| New | +$164K | ﹤0.01% | 1606 |
|